Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.
Skeptics of prescription weight-loss medications say that these drugs may not be the quick fix that many people hope for.
Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...
It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...
A healthy high protein prepared meal including chicken, carrots, fruits and greens. Taking Wegovy (semaglutide) can be a ...
(The Hill) — The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was linked with a near halving of ...
Semaglutide is sold as Wegovy for weight-loss and Ozempic for diabetes. At 72 weeks, 37% of patients on the drug showed improvement in liver scarring, with no worsening of steatohepatitis ...
Novo Nordisk (NVO) announced Friday a pivotal Phase 3 trial designed to test its weight loss therapy semaglutide on patients with a liver disease called metabolic dysfunction-associated ...